DHR Danaher Corporation

$230.69

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending 2025-12-31
Expected on Jan 28, 2026
Report Time: Before the Bell
The Whisper Number
$2.34
Consensus Estimate: $2.14
Revenue Estimate: $6.79B

Latest Earnings Insight

Danaher Corporation, with its substantial market cap of approximately $145 billion, is poised to report its third-quarter earnings on October 21, 2025, amid a backdrop of strategic realignments and market anticipation. Investors are keenly watching Danaher's performance, particularly given the company's historical strength in life sciences and diagnostics. The EPS estimate stands at $1.72, but the whisper number suggests a slightly more optimistic outlook at $1.81, indicating that market insiders might expect Danaher to outperform consensus expectations. Revenue is projected at $6.00 billion, reflecting the company's robust operational capabilities and its strategic focus on high-growth sectors. As Danaher continues to leverage its diversified portfolio and innovative solutions, the upcoming earnings report will be pivotal in assessing how well the company is navigating current market dynamics and sustaining its growth trajectory.

Updated On 1/6/2026

About Danaher Corporation

Danaher Corporation is an American globally diversified conglomerate with its headquarters in Washington, D.C.. The company designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company's 3 platforms are Life Sciences, Diagnostics, and Environmental & Applied Solutions.

Website: https://www.danaher.com

Sector
LIFE SCIENCES
Industry
INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
313616
Address
2200 PENNSYLVANIA AVE. N.W., SUITE 800W, WASHINGTON, DC, US
Valuation
Market Cap
$133.67B
P/E Ratio
35.32
PEG Ratio
1.86
Price to Book
2.70
Performance
EPS
$5.29
Dividend Yield
0.69%
Profit Margin
16.30%
ROE
7.57%
Technicals
50D MA
$203.24
200D MA
$239.91
52W High
$280.67
52W Low
$171.00
Fundamentals
Shares Outstanding
715M
Target Price
$255.02
Beta
0.90

DHR EPS Estimates vs Actual

Estimated
Actual

DHR News & Sentiment

Dec 31, 2025 • MarketBeat BULLISH
Meridian Financial Partners LLC Takes $896,000 Position in Danaher Corporation $DHR
Meridian Financial Partners LLC has initiated an $896,000 position in Danaher Corporation (NYSE:DHR) by acquiring 4,373 shares in the third quarter. The article highlights other institutional adjustments in Danaher, which reported strong Q3 earnings exceeding expectations with $1.89 EPS and $6.05 billion in revenue. Danaher also declared a quarterly dividend of $0.32, has a "Moderate Buy" consensus analyst rating, and maintains a market capitalization of approximately $163 billion.
Dec 31, 2025 • MarketBeat SOMEWHAT-BULLISH
Calamos Wealth Management LLC Has $16.98 Million Stake in Danaher Corporation $DHR
Calamos Wealth Management LLC increased its stake in Danaher Corporation by 41.0% in the third quarter, now holding 85,624 shares valued at approximately $16.98 million. Despite institutional buying, company insiders have been net sellers, disposing of over $6.6 million worth of shares recently. Danaher beat its Q3 earnings estimates, reporting $1.89 EPS on $6.05 billion revenue, and maintains a "Moderate Buy" consensus rating among analysts.
Dec 31, 2025 • MarketBeat SOMEWHAT-BULLISH
Calamos Advisors LLC Sells 36,163 Shares of Danaher Corporation $DHR
Calamos Advisors LLC reduced its stake in Danaher Corporation by 13.9% in Q3, selling 36,163 shares and retaining 223,518 shares valued at $44.3 million. Company insiders also sold 30,248 shares over the past three months, yet institutional investors still hold 79.05% of the stock. Analysts maintain a "Moderate Buy" rating with a consensus target price of $248.25 following strong Q3 earnings and a declared quarterly dividend.
Dec 31, 2025 • AD HOC NEWS BULLISH
The Truth About Danaher Corp: Hidden Giant Every Investor Keeps Sleeping On
Danaher Corp (DHR) is presented as a "hidden giant" in life sciences, diagnostics, and environmental technology, contrasting with popular meme stocks. The article highlights its consistent performance, essential business model ("picks-and-shovels" for science), and strong fundamentals as reasons for its appeal to serious long-term investors. It concludes that DHR is a quiet game-changer for a diversified portfolio focused on quality and long-term structural trends, rather than a speculative, high-hype stock.
Dec 31, 2025 • AD HOC NEWS BULLISH
The Truth About Danaher Corp: Hidden Giant Every Investor Keeps Sleeping On
Danaher Corp (DHR) is presented as a "hidden giant" in life sciences, diagnostics, and environmental tech, often overlooked by investors chasing meme stocks. The article highlights its consistent performance, essential business model ("picks-and-shovels" for science), and strong fundamentals as reasons for its appeal to serious long-term investors, contrasting it with trend-driven viral stocks. It emphasizes DHR's focus on recurring revenue and stability over flashy, short-term gains, positioning it as a foundational asset for a diversified portfolio.
Dec 31, 2025 • openPR.com SOMEWHAT-BULLISH
Japan Nucleic Acid Isolation and Purification Market is Driven by Biotech Research and Genomic Advancements | Top Companies - MP Biomedicals, Illumina Inc., General Electric Company
The Japan Nucleic Acid Isolation and Purification Market is projected to grow at a CAGR of 4.8% from 2024 to 2031, driven by advancements in biotech research and genomics. Key market players include MP Biomedicals, Illumina Inc., and General Electric Company. Recent industry developments in Japan highlight innovations in rapid viral RNA extraction, automated nucleic acid isolation, magnetic bead kits for mRNA vaccine QC, and customization centers for extraction reagents.
Sentiment Snapshot

Average Sentiment Score:

0.203
50 articles with scored sentiment

Overall Sentiment:

Bullish

DHR Reported Earnings

Jul 22, 2025
Jun 30, 2025 (Pre market)
-0.41 Surprise
  • Reported EPS: $0.77
  • Estimate: $1.18
  • Whisper:
  • Surprise %: -34.8%
Apr 22, 2025
Mar 31, 2025 (Pre market)
0.24 Surprise
  • Reported EPS: $1.88
  • Estimate: $1.64
  • Whisper:
  • Surprise %: 14.6%
Jan 29, 2025
Dec 31, 2024 (Pre market)
-0.24 Surprise
  • Reported EPS: $1.49
  • Estimate: $1.73
  • Whisper:
  • Surprise %: -13.9%
Oct 22, 2024
Sep 30, 2024 (Pre market)
0.14 Surprise
  • Reported EPS: $1.71
  • Estimate: $1.57
  • Whisper:
  • Surprise %: 8.9%
Jul 23, 2024
Jun 30, 2024 (Pre market)
0.15 Surprise
  • Reported EPS: $1.72
  • Estimate: $1.57
  • Whisper:
  • Surprise %: 9.6%
Apr 23, 2024
Mar 31, 2024 (Pre market)
0.21 Surprise
  • Reported EPS: $1.92
  • Estimate: $1.71
  • Whisper:
  • Surprise %: 12.3%
Jan 30, 2024
Dec 31, 2023 (Pre market)
0.18 Surprise
  • Reported EPS: $2.09
  • Estimate: $1.91
  • Whisper:
  • Surprise %: 9.4%
Oct 24, 2023
Sep 30, 2023 (Pre market)
0.14 Surprise
  • Reported EPS: $2.02
  • Estimate: $1.88
  • Whisper:
  • Surprise %: 7.5%
Jul 25, 2023
Jun 30, 2023 (Pre market)
0.03 Surprise
  • Reported EPS: $2.05
  • Estimate: $2.02
  • Whisper:
  • Surprise %: 1.5%

Financials